Aligos Therapeutics logo

Aligos Therapeutics share price today

(ALGS)

Aligos Therapeutics share price is $39.34 & ₹3,351.69 as on 25 Dec 2024, 2.30 'hrs' IST

$39.34

0.49

(1.26%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Aligos Therapeutics share price in Dollar and Rupees. Guide to invest in Aligos Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Aligos Therapeutics. Get details on the Indian mutual funds that are investing in Aligos Therapeutics. Get Analyst recommendations and forecasts along with all the Aligos Therapeutics's financials.

Aligos Therapeutics share price movements

  • Today's Low: $38.91
    Today's High: $42.28

    Day's Volatility :7.97%

  • 52 Weeks Low: $6.76
    52 Weeks High: $42.95

    52 Weeks Volatility :84.26%

Aligos Therapeutics Returns

PeriodAligos Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
390.52%
-9.0%
0.0%
6 Months
315.86%
-4.6%
0.0%
1 Year
113.11%
3.0%
0.0%
3 Years
-87.27%
0.0%
-21.1%

Aligos Therapeutics Key Statistics

in dollars & INR

Previous Close
$38.85
Open
$40.98
Today's High
$42.2795
Today's Low
$38.91
Market Capitalization
$141.1M
Today's Volume
$290.2K
52 Week High
$42.9471
52 Week Low
$6.76
Revenue TTM
$6.0M
EBITDA
$-92.7M
Earnings Per Share (EPS)
$-7.25
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-146.69%

How to invest in Aligos Therapeutics from India?

It is very easy for Indian residents to invest directly in Aligos Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Aligos Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Aligos Therapeutics or ALGS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Aligos Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Aligos Therapeutics shares which would translate to 0.022 fractional shares of Aligos Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Aligos Therapeutics, in just a few clicks!

Returns in Aligos Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Aligos Therapeutics investment value today

Current value as on today

₹2,15,348

Returns

₹1,15,348

(+115.35%)

Returns from Aligos Therapeutics Stock

₹1,13,109 (+113.11%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Aligos Therapeutics

10%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Aligos Therapeutics on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 10% more investors are searching Aligos Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Aligos Therapeutics

  • Armistice Capital, LLC

    8.78%

  • EcoR1 Capital, LLC

    7.12%

  • Deep Track Capital, LP

    6.80%

  • Adage Capital Partners Gp LLC

    6.10%

  • Vivo Capital, LLC

    3.95%

  • Woodline Partners LP

    2.56%

Analyst Recommendation on Aligos Therapeutics

Buy

    75%Buy

    25%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Aligos Therapeutics(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Aligos Therapeutics

What analysts predicted

Upside of 162.67%

Current:

$39.34

Target:

$103.33

Insights on Aligos Therapeutics

  • Price Movement

    In the last 3 months, ALGS stock has moved up by 390.5%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 986.0K → 1.26M (in $), with an average increase of 11.7% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 5.06M → -19.25M (in $), with an average decrease of 480.5% per quarter
  • ALGS vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 111.9%

Aligos Therapeutics Technicals Summary

Sell

Neutral

Buy

Aligos Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Aligos Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Aligos Therapeutics Inc
84.26%
315.86%
113.11%
-87.27%
-89.4%
Regeneron Pharmaceuticals, Inc.
-5.12%
-32.01%
-18.29%
12.56%
91.19%
Biontech Se
-3.72%
41.99%
6.11%
-55.22%
226.93%
Alnylam Pharmaceuticals, Inc.
-3.99%
-1.52%
23.75%
50.98%
112.09%
Vertex Pharmaceuticals Incorporated
-12.61%
-13.61%
0.03%
83.58%
86.41%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Aligos Therapeutics Inc
NA
NA
NA
-10.36
-1.47
-0.67
NA
15.07
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Aligos Therapeutics Inc
Buy
$141.1M
-89.4%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
91.19%
17.67
33.61%
Biontech Se
Buy
$27.4B
226.93%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.4B
112.09%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$105.1B
86.41%
32.84
-4.51%

About Aligos Therapeutics

aligos therapeutics, inc., a biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. its lead drug candidate is alg-010133, a synthetic oligonucleotide that is in phase i clinical trial for the treatment of chronic hepatitis b (chb). the company is also developing alg-000184, a capsid assembly modulator to treat chb; alg-020572, a oligonucleotide for the treatment of chb; alg-125097, an sirna drug candidate to treat chb; and alg-055009, a small molecule thr-㟠agonist for the treatment of non-alcoholic steatohepatitis. aligos therapeutics, inc. was founded in 2018 and is headquartered in south san francisco, california.
Organization
Aligos Therapeutics
Employees
68
CEO
Dr. Lawrence M. Blatt MBA, Ph.D.
Industry
Health Technology

Management People of Aligos Therapeutics

NameTitle
Dr. Lawrence M. Blatt MBA, Ph.D.
CEO, President & Chairman of the Board
Dr. Julian A. Symons DPHIL
Executive VP & Chief Scientific Officer
Ms. Lesley Ann Calhoun CPA
Executive VP & CFO
Ms. Kristina Engeseth M.B.A.
VP and Head of People & Culture
Dr. Sushmita M. Chanda DABT, Ph.D.
Executive Vice President & Chief Development Officer
Dr. David B. Smith Ph.D.
Executive VP & Head of Chemical Operations
Dr. Tse-I Lin Ph.D.
VP of Early Compound Development & Belgian Site Head
Dr. Hardean E. Achneck M.D.
Chief Medical Officer

Important FAQs about investing in Aligos Therapeutics from India :

What is Aligos Therapeutics share price today?

Aligos Therapeutics share price today stands at $39.34, Open: $40.98 ; Previous Close: $38.85 ; High: $42.28 ; Low: $38.91 ; 52 Week High: $42.95 ; 52 Week Low: $6.76. The stock opens at $40.98, after a previous close of $38.85. The stock reached a daily high of $42.28 and a low of $38.91, with a 52-week high of $42.95 and a 52-week low of $6.76.

Can Indians buy Aligos Therapeutics shares?

Yes, Indians can invest in the Aligos Therapeutics (ALGS) from India.

With INDmoney, you can buy Aligos Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Aligos Therapeutics at zero transaction cost.

How can I buy Aligos Therapeutics shares from India?

It is very easy to buy Aligos Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Aligos Therapeutics be purchased?

Yes, you can buy fractional shares of Aligos Therapeutics with INDmoney app.

What are the documents required to start investing in Aligos Therapeutics stocks?

To start investing in Aligos Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Aligos Therapeutics

Today’s highest price of Aligos Therapeutics (ALGS) is $42.28.

Today’s lowest price of Aligos Therapeutics (ALGS) is $38.91.

What is today's market capitalisation of Aligos Therapeutics

Today's market capitalisation of Aligos Therapeutics ALGS is 141.1M

What is the 52 Week High and Low Range of Aligos Therapeutics

  • 52 Week High

    $42.95

  • 52 Week Low

    $6.76

What are the historical returns of Aligos Therapeutics?

  • 1 Month Returns

    84.26%

  • 3 Months Returns

    315.86%

  • 1 Year Returns

    113.11%

  • 5 Years Returns

    -89.4%

Who is the Chief Executive Officer (CEO) of Aligos Therapeutics

Dr. Lawrence M. Blatt MBA, Ph.D. is the current Chief Executive Officer (CEO) of Aligos Therapeutics.